MDxHealth SA (OTCMKTS:MXDHF – Get Free Report)’s stock price fell 9.1% during trading on Monday . The company traded as low as $0.25 and last traded at $0.25. 300 shares traded hands during trading, a decline of 70% from the average session volume of 1,000 shares. The stock had previously closed at $0.28.
MDxHealth Stock Performance
The firm has a fifty day simple moving average of $0.43. The company has a debt-to-equity ratio of 1.45, a quick ratio of 1.19 and a current ratio of 1.25.
MDxHealth Company Profile
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications.
Featured Articles
- Five stocks we like better than MDxHealth
- Insider Buying Explained: What Investors Need to Know
- How to Invest in Silver: A Beginner’s Guide
- What Are Trending Stocks? Trending Stocks Explained
- Monday.com’s Stock Results Will Brighten Any Investor’s Week
- What is the Dogs of the Dow Strategy? Overview and Examples
- 3 Must-Watch Stocks After a Bullish Goldman Sachs Recommendation
Receive News & Ratings for MDxHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MDxHealth and related companies with MarketBeat.com's FREE daily email newsletter.